Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/17/2026

Glycemic Targets and Monitoring in Pregnancy for Women with Diabetes

Overall Glycemic Targets

  • The American Diabetes Association (ADA) recommends fasting glucose < 95 mg/dL, 1‑hour post‑prandial < 140 mg/dL, and 2‑hour post‑prandial < 120 mg/dL for all pregnant women with diabetes, provided these goals can be met without significant hypoglycemia【1】.

Targets by Diabetes Type

Gestational Diabetes (diet‑controlled)

  • For women with gestational diabetes not requiring insulin, the same targets apply: fasting < 95 mg/dL, 1‑hour post‑prandial < 140 mg/dL, and 2‑hour post‑prandial < 120 mg/dL【1】.

Pre‑existing Diabetes (Type 1 or Type 2)

  • The ADA advises tighter ranges: fasting/pre‑prandial 70–95 mg/dL, 1‑hour post‑prandial 110–140 mg/dL, and 2‑hour post‑prandial 100–120 mg/dL【2】.

HbA1c Goals and Monitoring

  • An HbA1c < 6 % (42 mmol/mol) is the preferred target when achievable without hypoglycemia; the goal may be relaxed to < 7 % (53 mmol/mol) if stricter control increases hypoglycemia risk【1】【2】.
  • Monthly HbA1c measurement is recommended because pregnancy accelerates red‑cell turnover, which physiologically lowers HbA1c values【1】【2】.
  • HbA1c should be considered a secondary metric, as it does not capture post‑prandial glucose excursions that drive fetal macrosomia【2】.

Self‑Monitoring of Blood Glucose (SMBG)

  • The ADA requires SMBG 4–6 times daily: daily fasting glucose, pre‑prandial checks for patients on insulin pump or basal‑bolus regimens, and post‑prandial measurements after each meal (either 1‑hour or 2‑hour)【1】【2】.

Continuous Glucose Monitoring (CGM)

  • In type 1 diabetic pregnant women, CGM can improve overall glycemic control and reduce the incidence of fetal macrosomia and neonatal hypoglycemia, but it does not replace capillary SMBG for meeting traditional pre‑ and post‑prandial targets【1】.

Guideline Recommendations and Evidence

  • Moderate‑quality evidence indicates that a fasting target < 90 mg/dL (versus < 95 mg/dL) is associated with a lower risk of macrosomia in gestational diabetes during the third trimester【2】.
  • The American College of Obstetricians and Gynecologists (ACOG) recommends a fasting target < 90 mg/dL, whereas the ADA recommends < 95 mg/dL【2】.
  • Clinically, it is reasonable to begin with the ADA target (< 95 mg/dL) and tighten to < 90 mg/dL if fetal ultrasound shows macrosomia or if tighter control can be achieved without hypoglycemia【1】【2】.

Multidisciplinary Care

  • Referral to a specialized diabetes‑in‑pregnancy center with a multidisciplinary team (maternal‑fetal medicine, endocrinology, diabetes education, nutrition) is strongly advised to manage complex insulin adjustments throughout pregnancy【1】.

Target Blood Sugar Levels in Pregnancy

Introduction to Targets

  • The American Diabetes Association recommends target fasting blood glucose <95 mg/dL and either 1-hour postprandial <140 mg/dL or 2-hour postprandial <120 mg/dL to minimize risks of macrosomia, neonatal complications, and maternal morbidity 3

Specific Targets by Diabetes Type

  • For women with Gestational Diabetes Mellitus (GDM) not on insulin, the American Diabetes Association recommends fasting glucose: <95 mg/dL, 1-hour postprandial: <140 mg/dL, and 2-hour postprandial: <120 mg/dL 3, 4
  • For women with GDM treated with insulin, the American Diabetes Association recommends fasting glucose: 70-95 mg/dL, 1-hour postprandial: 110-140 mg/dL, and 2-hour postprandial: 100-120 mg/dL 3, 4
  • For women with preexisting diabetes, the American Diabetes Association recommends fasting/premeal glucose: 70-95 mg/dL, 1-hour postprandial: 110-140 mg/dL, and 2-hour postprandial: 100-120 mg/dL 3, 4

A1C Targets

  • The American Diabetes Association recommends target A1C <6% if achievable without significant hypoglycemia; may relax to <7% if necessary to prevent hypoglycemia 3, 4
  • A1C <6% is associated with the lowest risk of large-for-gestational-age infants, preterm delivery, and preeclampsia in the second and third trimesters 3
  • A1C should be monitored monthly during pregnancy due to increased red blood cell turnover that physiologically lowers A1C 3, 4

Continuous Glucose Monitoring Targets

  • For women using Continuous Glucose Monitoring (CGM), the American Diabetes Association recommends target sensor glucose range: 63-140 mg/dL, time in range goal: >70%, time below range <63 mg/dL: goal <4%, and time below range <54 mg/dL: goal <1% 3

Monitoring Strategy

  • The American Diabetes Association recommends performing fasting, preprandial, and postprandial blood glucose monitoring to achieve optimal glucose levels 3, 4

Critical Pitfalls to Avoid

  • Early pregnancy presents enhanced insulin sensitivity with significantly increased hypoglycemia risk; targets must be achieved without causing significant hypoglycemia 3, 4
  • Hypoglycemia in pregnancy may increase the risk of low birth weight 3
  • Insulin requirements typically decrease in the first trimester, then increase exponentially during the second trimester and plateau in the third trimester 5
  • Red blood cell turnover increases during pregnancy, causing A1C to fall even with stable glucose control 3, 4